"Experimental Oncology" . . . . "Pou\u017Eit\u00ED mnoho\u010Detn\u00FDch biomarker\u016F pro hodnocen\u00ED kardiotoxicity vyvolan\u00E9 antracykliny u pacient\u016F s akutn\u00ED myeloidn\u00ED leuk\u00E9mi\u00ED"@cs . "[A072A63D208B]" . "UA - Ukrajina" . "Hor\u00E1\u010Dek, Jan" . . "6"^^ . "Pudil, R." . . . . "30" . . "Jebav\u00FD, Ladislav" . "\u010Cl\u00E1nek pojedn\u00E1v\u00E1 o hodnocen\u00ED kardi\u00E1ln\u00ED toxicity antracyklin\u016F pomoc\u00ED sady \u0161esti biomarker\u016F kardi\u00E1ln\u00EDho po\u0161kozen\u00ED (myoglobin, CK - MB mass, cTnT, cTnI, H-FABP, BPBB). Stanoven\u00ED GPBB by se mohlo st\u00E1t nad\u011Bjn\u00FDm ukazatelem pro detekci kardiotoxicity antracyklin\u016F a mo\u017En\u00E1 i lep\u0161\u00EDm ne\u017E kardi\u00E1ln\u00ED proponiny."@cs . . . . . "The article deals with the assesment of cardiac toxicity of antracycline trestment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK - MB mass), cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), glycogen phosphorylase BB (GPBB). GPBB could be a new promising marker for detection of anthracycline-related cardiotoxicity and probably superior to cardiac troponins." . . "Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia" . "cardiac biomarkers; glycogen phosphorylase BB; cardiotoxicity; anthracyclines; chemoterapy; acute myeloid leukemia"@en . . "Ulrychov\u00E1, M." . . . . "RIV/60162694:G44__/08:00002058" . "3"^^ . "Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia"@en . "2" . "Mal\u00FD, J." . . "Tich\u00FD, Milo\u0161" . "Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia"@en . "1812-9269" . "401772" . "RIV/60162694:G44__/08:00002058!RIV09-MO0-G44_____" . "Use of multiple biomarkers for evaluation of antracycline-induced cardiotoxicity in patients with acute myeloid leukemia" . "3"^^ . . "G44" . . "Pou\u017Eit\u00ED mnoho\u010Detn\u00FDch biomarker\u016F pro hodnocen\u00ED kardiotoxicity vyvolan\u00E9 antracykliny u pacient\u016F s akutn\u00ED myeloidn\u00ED leuk\u00E9mi\u00ED"@cs . "The article deals with the assesment of cardiac toxicity of antracycline trestment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK - MB mass), cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), glycogen phosphorylase BB (GPBB). GPBB could be a new promising marker for detection of anthracycline-related cardiotoxicity and probably superior to cardiac troponins."@en . "Z(MO0FVZ0000503)" .